CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma-Reference-Cited by-同舟云学术

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma

Published:2017-07-20 Issue:48 Volume:8 Page:83673-83683
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ru Guo-Qing¹,Han Yong²,Wang Wei¹,Chen Yuan¹,Wang Hui-Ju²,Xu Wen-Juan¹,Ma Jie¹,Ye Meihua¹,Chen Xi³,He Xiang-Lei¹,Győrffy Balázs⁴⁵,Zhao Zhong-Sheng¹,Huang Dongsheng²

Affiliation:

1. Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, PR China

2. Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, PR China

3. VIP Medical Center, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, PR China

4. Momentum Cancer Biomarker Research Group, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary

5. Second Department of Pediatrics, Semmelweis University, Budapest, Hungary

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells;Current Cancer Drug Targets;2024-07

2. CEACAM6 expression and function in tumor biology: a comprehensive review;Discover Oncology;2024-05-25

3. Smoking changes adaptive immunity with persistent effects;Nature;2024-02-14

4. The emerging roles of CEACAM6 in human cancer (Review);International Journal of Oncology;2024-01-18

5. Identification of driving genes of familial adenomatous polyposis by differential gene expression analysis and weighted gene co-expression network analysis;Technology and Health Care;2023-11-23